MiR-7015-3p Targets Nuclear Factor-Kappa-B-Inhibitor Alpha to Aggravate Hypoxia/Reoxygenation Injury in Cardiomyocytes Through the NF-κB Pathway

MiR-7015-3p 通过 NF-κB 通路靶向核因子 κB 抑制剂 α 加重心肌细胞缺氧/复氧损伤

阅读:10

Abstract

Ischemic heart disease (IHD) is a prominent global cause of morbidity and death resulting from the narrowing or blockage of cardiac coronary arteries. Exposing isolated cardiac myocytes to hypoxia-reoxygenation (H/R) might be an efficient tool to investigate the etiology and underlying mechanism of myocardial ischemia-reperfusion (I/R) injury. This study found that miR-7015 is upregulated in mouse myocardial tissues after I/R injury and in cardiomyocytes after H/R injury. A model of H/R-induced cardiomyocyte injury was established; miR-7015 overexpression exacerbated while miR-7015 inhibition partially ameliorated H/R-induced cardiomyocyte injury by inhibiting cytokine release, promoting cell viability, and suppressing apoptosis. Bioinformatics and experimental studies have identified nuclear factor-kappa-B-inhibitor alpha (Nfkbia) as a direct downstream target of miR-7015. miR-7015 inhibited Nfkbia expression. Unlike miR-7015 overexpression, Nfkbia overexpression alleviated H/R-induced injury in cardiomyocytes. Moreover, Nfkbia overexpression partially abolished the effects of miR-7015 overexpression on H/R-induced cardiomyocyte injury. In conclusion, the miR-7015/Nfkbia axis modulates cardiomyocyte injury induced by H/R, possibly through the NF-κB signaling.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。